Kevin T McVary. Show Affiliations »
Abstract
Mesh: See more » 3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors3',5'-Cyclic-GMP Phosphodiesterases/metabolismAgedAged, 80 and overErectile Dysfunction/complicationsErectile Dysfunction/drug therapyErectile Dysfunction/enzymologyHumansMaleMiddle AgedPelvis/physiopathologyPhosphodiesterase Inhibitors/therapeutic useProstatic Hyperplasia/complicationsProstatic Hyperplasia/drug therapyProstatic Hyperplasia/enzymologyUrinary Bladder Diseases/complicationsUrinary Bladder Diseases/drug therapyUrinary Bladder Diseases/enzymology
Substances: See more » Phosphodiesterase Inhibitors3',5'-Cyclic-GMP Phosphodiesterases
Year: 2006 PMID: 17045387 DOI: 10.1016/j.eururo.2006.09.014
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096